Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma journalArticle 2016 Gunn, G. B.; Blanchard, P.; Garden, A. S.; Zhu, X. R.; Fuller, C. D.; Mohamed, A. S.; Morrison, W. H.; Phan, J.; Beadle, B. M.; Skinner, H. D.; Sturgis, E. M.; Kies, M. S.; Hutcheson, K. A.; Rosenthal, D. I.; Mohan, R.; Gillin, M. T.; Frank, S. J.
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has journalArticle 2015 Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I.
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has journalArticle 2015 Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I.
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis journalArticle 2018 Guerrini-Rousseau, L.; Dufour, C.; Varlet, P.; Masliah-Planchon, J.; Bourdeaut, F.; Guillaud-Bataille, M.; Abbas, R.; Bertozzi, A. I.; Fouyssac, F.; Huybrechts, S.; Puget, S.; Bressac-De Paillerets, B.; Caron, O.; Sevenet, N.; Dimaria, M.; Villebasse, S.; Delattre, O.; Valteau-Couanet, D.; Grill, J.; Brugières, L.
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors journalArticle 2018 Guerrero-Zotano, A.; Stricker, T.; Formisano, L.; Hutchinson, K. E.; Stover, D. G.; Lee, K. M.; Schwarz, L. J.; Giltnane, J. M.; Estrada, M. V.; Jansen, V. M.; Servetto, A.; Gavilá, J.; Pérez-Fidalgo, J. A.; Lluch, A.; Llombart-Cussac, A.; Bayar, M. A.; Michiels, S.; Andre, F.; Arnedos, M.; Guillem, V.; Ruiz-Simon, A.; Arteaga, C. L.
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite journalArticle 2015 Grünewald, T. G.; Bernard, V.; Gilardi-Hebenstreit, P.; Raynal, V.; Surdez, D.; Aynaud, M. M.; Mirabeau, O.; Cidre-Aranaz, F.; Tirode, F.; Zaidi, S.; Perot, G.; Jonker, A. H.; Lucchesi, C.; Le Deley, M. C.; Oberlin, O.; Marec-Bérard, P.; Véron, A. S.; Reynaud, S.; Lapouble, E.; Boeva, V.; Rio Frio, T.; Alonso, J.; Bhatia, S.; Pierron, G.; Cancel-Tassin, G.; Cussenot, O.; Cox, D. G.; Morton, L. M.; Machiela, M. J.; Chanock, S. J.; Charnay, P.; Delattre, O.
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma journalArticle 2018 Grill, J.; Massimino, M.; Bouffet, E.; Azizi, A. A.; McCowage, G.; Canete, A.; Saran, F.; Le Deley, M. C.; Varlet, P.; Morgan, P. S.; Jaspan, T.; Jones, C.; Giangaspero, F.; Smith, H.; Garcia, J.; Elze, M. C.; Rousseau, R. F.; Abrey, L.; Hargrave, D.; Vassal, G.
Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma journalArticle 2018 Gravel, G.; Leboulleux, S.; Tselikas, L.; Fassio, F.; Berraf, M.; Berdelou, A.; Ba, B.; Hescot, S.; Hadoux, J.; Schlumberger, M.; Al Ghuzlan, A.; Nguyen, F.; Faron, M.; de Baere, T.; Baudin, E.; Deschamps, F.
[Post-treatment follow-up of head and neck cancer patients] journalArticle 2019 Graff, P.; Blanchard, P.; Thariat, J.; Racadot, S.; Lapeyre, M.
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer journalArticle 2016 Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer journalArticle 2016 Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) journalArticle 2015 Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.
Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy journalArticle 2016 Gorphe, P.; Matias, M.; Moya-Plana, A.; Tabarino, F.; Blanchard, P.; Tao, Y.; Janot, F.; Temam, S.
Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy journalArticle 2016 Gorphe, P.; Matias, M.; Moya-Plana, A.; Tabarino, F.; Blanchard, P.; Tao, Y.; Janot, F.; Temam, S.
Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma journalArticle 2016 Gorphe, P.; Matias, M.; Even, C.; Ferte, C.; Bidault, F.; Garcia, G.; Temam, S.; Nguyen, F.; Blanchard, P.; Tao, Y.; Janot, F.
Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma journalArticle 2016 Gorphe, P.; Matias, M.; Even, C.; Ferte, C.; Bidault, F.; Garcia, G.; Temam, S.; Nguyen, F.; Blanchard, P.; Tao, Y.; Janot, F.
Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation journalArticle 2018 Gorphe, P.; Chekkoury Idrissi, Y.; Tao, Y.; Schernberg, A.; Ou, D.; Temam, S.; Casiraghi, O.; Blanchard, P.; Mirghani, H.
Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma journalArticle 2019 Gorphe, P.; Chekkoury Idrissi, Y.; Tao, Y.; Moya-Plana, A.; Casiraghi, O.; Janot, F.; Blanchard, P.; Mirghani, H.; Temam, S.
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F.
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F.
Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey journalArticle 2016 Gorphe, P.; Blanchard, P.; Moriniere, S.; Fakhry, N.
Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey journalArticle 2016 Gorphe, P.; Blanchard, P.; Moriniere, S.; Fakhry, N.
Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Breuskin, I.; Temam, S.; Tao, Y.; Janot, F.
Revisiting vascular contraindications for transoral robotic surgery for oropharyngeal cancer journalArticle 2018 Gorphe, P.; Auperin, A.; Honart, J. F.; Ton Van, J.; El Bedoui, S.; Bidault, F.; Temam, S.; Kolb, F.; Qassemyar, Q.
Peritoneal Metastases from Colorectal Cancer: Treatment Principles and Perspectives journalArticle 2018 Goere, D.; Sourrouille, I.; Gelli, M.; Benhaim, L.; Faron, M.; Honore, C.
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973) journalArticle 2018 Goéré, D.; Pignon, J. P.; Gelli, M.; Elias, D.; Benhaim, L.; Deschamps, F.; Caramella, C.; Boige, V.; Ducreux, M.; de Baere, T.; Malka, D.
Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours journalArticle 2016 Gizzi, M.; Oberic, L.; Massard, C.; Poterie, A.; Gwenael, L. T.; Loriot, Y.; Albiges, L.; Baciarello, G.; Michels, J.; Bossi, A.; Blanchard, P.; Escudier, B.; Fizazi, K.
Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours journalArticle 2016 Gizzi, M.; Oberic, L.; Massard, C.; Poterie, A.; Gwenael, L. T.; Loriot, Y.; Albiges, L.; Baciarello, G.; Michels, J.; Bossi, A.; Blanchard, P.; Escudier, B.; Fizazi, K.
Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review journalArticle 2016 Gault, N.; Castaneda-Sanabria, J.; Guillo, S.; Foulon, S.; Tubach, F.
Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review journalArticle 2016 Gault, N.; Castaneda-Sanabria, J.; Guillo, S.; Foulon, S.; Tubach, F.
LONG-TERM SURVIVAL IN PATIENTS RESPONDING TO ANTI-PD-1/PD-L1 THERAPY AND DISEASE OUTCOME UPON TREATMENT DISCONTINUATION journalArticle 2018 Gauci, M. L.; Lanoy, E.; Champiat, S.; Caramella, C.; Ammari, S.; Aspeslagh, S.; Varga, A.; Baldini, C.; Bahleda, R.; Gazzah, A.; Michot, J. M.; Postel-Vinay, S.; Angevin, E.; Ribrag, V.; Hollebecque, A.; Soria, J. C.; Robert, C.; Massard, C.; Marabelle, A.
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study journalArticle 2018 Gaspar, N.; Occean, B. V.; Pacquement, H.; Bompas, E.; Bouvier, C.; Brisse, H. J.; Castex, M. P.; Cheurfa, N.; Corradini, N.; Delaye, J.; Entz-Werle, N.; Gentet, J. C.; Italiano, A.; Lervat, C.; Marec-Berard, P.; Mascard, E.; Redini, F.; Saumet, L.; Schmitt, C.; Tabone, M. D.; Verite-Goulard, C.; Le Deley, M. C.; Piperno-Neumann, S.; Brugieres, L.; Sfce; Gsf, Geto; group, Unicancer sarcoma
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration journalArticle 2015 Gaspar, N.; Hawkins, D. S.; Dirksen, U.; Lewis, I. J.; Ferrari, S.; Le Deley, M. C.; Kovar, H.; Grimer, R.; Whelan, J.; Claude, L.; Delattre, O.; Paulussen, M.; Picci, P.; Sundby Hall, K.; van den Berg, H.; Ladenstein, R.; Michon, J.; Hjorth, L.; Judson, I.; Luksch, R.; Bernstein, M. L.; Marec-Bérard, P.; Brennan, B.; Craft, A. W.; Womer, R. B.; Juergens, H.; Oberlin, O.
Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma journalArticle 2018 Gambachidze, D.; Lebacle, C.; Maroun, P.; Escande, A.; Bossi, A.; Blanchard, P.; Deutsch, E.; Haie-Meder, C.; Chargari, C.
Mineralogy and uranium leaching of ores from Triassic Peribaltic sandstones journalArticle 2015 Gajda, D.; Kiegiel, K.; Zakrzewska-Koltuniewicz, G.; Chajduk, E.; Bartosiewicz, I.; Wolkowicz, S.
Mineralogy and uranium leaching of ores from Triassic Peribaltic sandstones journalArticle 2015 Gajda, D.; Kiegiel, K.; Zakrzewska-Koltuniewicz, G.; Chajduk, E.; Bartosiewicz, I.; Wolkowicz, S.
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers journalArticle 2016 Fumagalli, D.; Wilson, T. R.; Salgado, R.; Lu, X.; Yu, J.; O'Brien, C.; Walter, K.; Huw, L. Y.; Criscitiello, C.; Laios, I.; Jose, V.; Brown, D. N.; Rothe, F.; Maetens, M.; Zardavas, D.; Savas, P.; Larsimont, D.; Piccart-Gebhart, M. J.; Michiels, S.; Lackner, M. R.; Sotiriou, C.; Loi, S.
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers journalArticle 2016 Fumagalli, D.; Wilson, T. R.; Salgado, R.; Lu, X.; Yu, J.; O'Brien, C.; Walter, K.; Huw, L. Y.; Criscitiello, C.; Laios, I.; Jose, V.; Brown, D. N.; Rothe, F.; Maetens, M.; Zardavas, D.; Savas, P.; Larsimont, D.; Piccart-Gebhart, M. J.; Michiels, S.; Lackner, M. R.; Sotiriou, C.; Loi, S.
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02) journalArticle 2018 Frikha, M.; Auperin, A.; Tao, Y.; Elloumi, F.; Toumi, N.; Blanchard, P.; Lang, P.; Sun, S.; Racadot, S.; Thariat, J.; Alfonsi, M.; Tuchais, C.; Cornely, A.; Moussa, A.; Guigay, J.; Daoud, J.; Bourhis, J.; Gortec
[Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database] journalArticle 2016 Freyer, G.; Scotte, F.; Borget, I.; Bruyas, A.; Vainchtock, A.; Chouaid, C.